Literature DB >> 24458518

Metastatic melanoma mimicking solitary fibrous tumor: report of two cases.

Elise M Bekers1, Adriana C H van Engen-van Grunsven, Patricia J T A Groenen, Harm Westdorp, Rutger H T Koornstra, Johannes J Bonenkamp, Uta Flucke, Willeke A M Blokx.   

Abstract

Malignant melanomas are known for their remarkable morphological variation and aberrant immunophenotype with loss of lineage-specific markers, especially in recurrences and metastases. Hot spot mutations in BRAF, NRAS, GNAQ, and GNA11 and mutations in KIT are oncogenic events in melanomas. Therefore, genotyping can be a useful ancillary diagnostic tool. We present one case each of recurrent and metastatic melanoma, both showing histological and immunohistochemical features of solitary fibrous tumor (SFT). Mutational analysis detected BRAF and NRAS mutations in the primary and secondary lesions, respectively. This result confirmed the diagnosis of recurrent/metastastic melanoma.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24458518     DOI： 10.1007/s00428-014-1542-5

Source DB:  PubMed          Journal:  Virchows Arch        ISSN： 0945-6317            Impact factor:   4.064


  36 in total

Review 1.  Ras, Raf, and MAP kinase in melanoma.

Authors:  Jason F Solus; Stefan Kraft
Journal:  Adv Anat Pathol       Date:  2013-07       Impact factor: 3.875

2.  Malignant perivascular melanoma mimicking primary central nervous system vasculitis.

Authors:  Martin Schneider; Jan Höltje; Uwe Kehler; Volker Hartmann; Konstanze Holl-Ullrich; Katrin Oechel; Peter Paul Urban
Journal:  J Neurol       Date:  2012-12-20       Impact factor: 4.849

3.  Frequency and spectrum of BRAF mutations in a retrospective, single-institution study of 1112 cases of melanoma.

Authors:  Wesley O Greaves; Shalini Verma; Keyur P Patel; Michael A Davies; Bedia A Barkoh; John M Galbincea; Hui Yao; Alexander J Lazar; Kenneth D Aldape; L Jeffrey Medeiros; Rajyalakshmi Luthra
Journal:  J Mol Diagn       Date:  2012-12-27       Impact factor: 5.568

4.  CD34 expression in desmoplastic melanoma.

Authors:  M P Hoang; M A Selim; R C Bentley; J L Burchette; C R Shea
Journal:  J Cutan Pathol       Date:  2001-11       Impact factor: 1.587

5.  Perineural extension of cutaneous desmoplastic melanoma mimicking an intracranial malignant peripheral nerve sheath tumor. Case report.

Authors:  Samuel L Barnett; Michael J Wells; Bruce Mickey; Kimmo J Hatanpaa
Journal:  J Neurosurg       Date:  2011-05-06       Impact factor: 5.115

6.  Frequency of KRAS, BRAF, and NRAS mutations in colorectal cancer.

Authors:  Cecily P Vaughn; Scott D Zobell; Larissa V Furtado; Christine L Baker; Wade S Samowitz
Journal:  Genes Chromosomes Cancer       Date:  2011-02-08       Impact factor: 5.006

7.  CDKN2A (INK4A-ARF) mutation analysis to distinguish cutaneous melanoma metastasis from a second primary melanoma.

Authors:  Willeke A M Blokx; W Joost Lesterhuis; Joost J Lesterhuis; Monique P M Andriessen; Marian A J Verdijk; Cornelis J A Punt; Kees J A Punt; Marjolijn J L Ligtenberg
Journal:  Am J Surg Pathol       Date:  2007-04       Impact factor: 6.394

8.  Characteristics of lung cancers harboring NRAS mutations.

Authors:  Kadoaki Ohashi; Lecia V Sequist; Maria E Arcila; Christine M Lovly; Xi Chen; Charles M Rudin; Teresa Moran; David Ross Camidge; Cindy L Vnencak-Jones; Lynne Berry; Yumei Pan; Hidefumi Sasaki; Jeffrey A Engelman; Edward B Garon; Steven M Dubinett; Wilbur A Franklin; Gregory J Riely; Martin L Sos; Mark G Kris; Dora Dias-Santagata; Marc Ladanyi; Paul A Bunn; William Pao
Journal:  Clin Cancer Res       Date:  2013-03-20       Impact factor: 12.531

9.  Melanoma masquerading as xanthogranuloma: a diagnostic pitfall.

Authors:  Munir H Idriss; Graciela De Jesús; Steve A McClain; Geoffrey J Gottlieb
Journal:  Am J Dermatopathol       Date:  2013-05       Impact factor: 1.533

10.  Mutation analysis of genes that control the G1/S cell cycle in melanoma: TP53, CDKN1A, CDKN2A, and CDKN2B.

Authors:  José Luis Soto; Carmen M Cabrera; Salvio Serrano; Miguel Angel López-Nevot
Journal:  BMC Cancer       Date:  2005-04-08       Impact factor: 4.430
View more
  2 in total

Review 1.  Update on Molecular Pathology of Cutaneous Melanocytic Lesions: What is New in Diagnosis and Molecular Testing for Treatment?

Authors:  Adriana C H van Engen-van Grunsven; Heidi Kusters-Vandevelde; Patricia J T A Groenen; Willeke A M Blokx
Journal:  Front Med (Lausanne)       Date:  2014-10-31

2.  Immunohistochemical and Molecular Features of Melanomas Exhibiting Intratumor and Intertumor Histomorphologic Heterogeneity.

Authors:  Haider A Mejbel; Sri Krishna C Arudra; Dinesh Pradhan; Carlos A Torres-Cabala; Priyadharsini Nagarajan; Michael T Tetzlaff; Jonathan L Curry; Doina Ivan; Dzifa Y Duose; Raja Luthra; Victor G Prieto; Leomar Y Ballester; Phyu P Aung
Journal:  Cancers (Basel)       Date:  2019-11-02       Impact factor: 6.639
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.